Omron (OTCMKTS:OMRNY) Reaches New 52-Week High on Analyst Upgrade

Omron Corp. (OTCMKTS:OMRNYGet Free Report) hit a new 52-week high during mid-day trading on Tuesday after Zacks Research upgraded the stock from a strong sell rating to a hold rating. The company traded as high as $43.48 and last traded at $43.4350, with a volume of 3277 shares trading hands. The stock had previously closed at $42.21.

Separately, Jefferies Financial Group lowered Omron from a “buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.

Get Our Latest Analysis on OMRNY

Omron Stock Performance

The business has a 50-day moving average price of $35.99 and a 200-day moving average price of $33.13. The firm has a market capitalization of $8.74 billion, a price-to-earnings ratio of 42.32, a P/E/G ratio of 0.64 and a beta of 1.14. The company has a quick ratio of 1.41, a current ratio of 1.83 and a debt-to-equity ratio of 0.08.

About Omron

(Get Free Report)

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

Further Reading

Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.